Association of muscle mass, grip strength and fat-to-muscle ratio and metabolic dysfunction-associated steatotic liver disease in a middle-to-elderly aged population

被引:1
|
作者
Liu, Siyang [1 ]
He, Yajun [1 ,2 ]
Yu, Genfeng [1 ]
Song, Cheng [1 ]
Wang, Dongmei [1 ]
Liu, Lan [1 ]
Liang, Hua [1 ]
Wan, Heng [1 ]
Shen, Jie [1 ]
机构
[1] Southern Med Univ, Shunde Hosp, Peoples Hosp Shunde 1, Inst & Dept Endocrinol & Metab, 1 Jiazi Rd, Foshan 528308, Guangdong, Peoples R China
[2] Southern Med Univ, Sch Nursing, Guangzhou, Guangdong, Peoples R China
基金
中国国家自然科学基金;
关键词
Fat-to-muscle ratio; appendicular skeletal muscle mass; grip strength; metabolic dysfunction-associated steatotic liver disease; liver fibrosis; KOREA NATIONAL-HEALTH; SARCOPENIC OBESITY; RISK; CONSUMPTION; MORTALITY; FIBROSIS; ADULTS;
D O I
10.1080/07853890.2024.2390169
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectiveThe association of appendicular skeletal muscle mass (ASM), grip strength and fat-to-muscle ratio (FMR) and the progression of metabolic dysfunction-associated steatotic liver disease (MASLD) are not well known.Materials and methodsThis study included participants older than 40 years who underwent bioelectrical impedance assessment in Prevalence of Metabolic Diseases and Risk Factors in Shunde (SPEED-Shunde). We measured grip strength with an electronic grip strength metre. ASM and grip strength were adjusted by dividing body mass index (BMI). FMR was calculated as total fat mass to total muscle mass. Liver steatosis and liver fibrosis were evaluated by vibration-controlled transient elastography. Multifactorial logistic regression was used to analyse the relationship between ASM, grip strength, FMR, and MASLD or MASLD-associated liver fibrosis. We performed subgroup analyses according to sex, age and BMI. Interaction tests and linear trend tests were also conducted.ResultsThis study included a total of 3277 participants. FMR was positively associated with MASLD (OR: 1.89, 95% CI: 1.66-2.15) and MASLD-associated liver fibrosis (OR: 1.70, 95% CI: 1.22-2.37). While ASM/BMI (OR: 0.59, 95% CI: 0.52-0.67) or grip strength/BMI (OR: 0.72, 95% CI: 0.66-0.78) were negatively associated with MASLD. Interactions were observed between ASM/BMI and age, grip strength and sex in MASLD, as well as FMR and MASLD-associated liver fibrosis.ConclusionIn a middle-to-elderly aged population, FMR was positively associated with the risk of MASLD and MASLD-associated liver fibrosis, and muscle mass and grip strength were negatively associated with MASLD, rather than MASLD-associated liver fibrosis.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Increased visceral fat area to skeletal muscle mass ratio is positively associated with the risk of metabolic dysfunction-associated steatotic liver disease in a Chinese population
    Liu, Chenbing
    Li, Nan
    Sheng, Di
    Shao, Yahong
    Qiu, Lihong
    Shen, Chao
    Liu, Zhong
    LIPIDS IN HEALTH AND DISEASE, 2024, 23 (01)
  • [2] Possible association between metabolic dysfunction-associated steatotic liver disease predictors and hand grip strength
    Suyeon Lee
    Jong-Koo Kim
    Taesic Lee
    Scientific Reports, 15 (1)
  • [3] Liver-muscle crosstalk in metabolic dysfunction-associated steatotic liver disease
    Fumo, A. R.
    Morigny, P.
    Ji, H.
    Maida, A.
    von Toerne, C.
    Alfaro, A. J.
    Motzler, K.
    Feuchtinger, A.
    Rohm, M.
    DIABETOLOGIA, 2024, 67 : S459 - S459
  • [4] The relationship between skeletal muscle mass to visceral fat area ratio and metabolic dysfunction-associated fatty liver disease subtypes in middle-aged and elderly population: a single-center retrospective study
    Xing, Mengchen
    Ni, Yanlan
    Zhang, Ye
    Zhao, Xiaoqian
    Yu, Xin
    FRONTIERS IN NUTRITION, 2023, 10
  • [5] Association between remnant cholesterol and metabolic dysfunction-associated steatotic liver disease in the elderly
    Lan, Yanqi
    Guo, Zhinan
    Dai, Junsheng
    Chen, Kailin
    Chen, Youlan
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (09) : 1557 - 1564
  • [6] Association of low muscle strength with metabolic dysfunction-associated fatty liver disease: A nationwide study
    Lee, Gyu Bae
    Huh, Youn
    Lee, Sang Hyun
    Han, Byoungduck
    Kim, Yang-Hyun
    Kim, Do-Hoon
    Kim, Seon Mee
    Choi, Youn Seon
    Cho, Kyung Hwan
    Nam, Ga Eun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2023, 29 (45) : 5962 - 5973
  • [7] Metabolic dysfunction-associated fatty liver disease and low muscle strength: A comment
    Karim, Masood Muhammad
    Butt, Amna Subhan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (17) : 2371 - 2373
  • [8] In Vitro Modeling of Fat Deposition in Metabolic Dysfunction-associated Steatotic Liver Disease
    Bao, Qinglan
    Zhang, Xiaoxiao
    Chen, Yingsong
    Wang, Tegexibaiyin
    Siqin, Bateer
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2024, (209):
  • [9] Effects of ipragliflozin on skeletal muscle adiposity in patients with diabetes and metabolic dysfunction-associated steatotic liver disease
    Ishimaru, Yuko
    Kessoku, Takaomi
    Nonaka, Michihiro
    Kitajima, Yoichiro
    Hyogo, Hideyuki
    Nakajima, Tomoaki
    Imajo, Kento
    Kubotsu, Yoshihito
    Isoda, Hiroshi
    Kawanaka, Miwa
    Yoneda, Masato
    Anzai, Keizo
    Nakajima, Atsushi
    Furukawa, Kyoji
    Kawaguchi, Atsushi
    Takahashi, Hirokazu
    INTERNAL MEDICINE, 2024,
  • [10] Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
    Sandireddy, Reddemma
    Sakthivel, Suganya
    Gupta, Priyanka
    Behari, Jatin
    Tripathi, Madhulika
    Singh, Brijesh Kumar
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2024, 12